Research ArticleNeuropharmacology
HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604
Xia-Yan Zhang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Xiao-Rong Wang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Dong-Min Xu
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Shu-Ying Yu
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Qiao-Juan Shi
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Li-Hui Zhang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Lu Chen
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
San-Hua Fang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Yun-Bi Lu
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Wei-Ping Zhang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Er-Qing Wei
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)

JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleNeuropharmacology
HAMI 3379 Attenuates Ischemia-Like Neuronal Injury
Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
Journal of Pharmacology and Experimental Therapeutics August 1, 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604
Research ArticleNeuropharmacology
HAMI 3379 Attenuates Ischemia-Like Neuronal Injury
Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
Journal of Pharmacology and Experimental Therapeutics August 1, 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604